Amberen
Natural health product licensed in Canada
- Other names
- Amberen-Capsule 1, Amberen-Capsule 2
- Licence holder
- Alliance Pharma Inc.
- NPN or DIN-HM
- 80108254
- Status
- Active licence
- Licence date
- 17 February 2021
- Revision date
- 28 February 2025
- Form
- Kit
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Disuccinate de Magnésium Tétrahydraté | 1.47 mg | Not calculated |
| Calcium Source : Disuccinate de Calcium Dihydraté | 11.885 mg | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 5.03 mg AT | Not calculated |
Non-medicinal ingredients
Riboflavine, Dioxyde de titane, Gélatine, farine de riz, Stéarate de magnésium, Eau, Carmine, Dioxyde de silice, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes adultes | Not specified | 1 Kit | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the relief of menopausal symptoms including hot flashes, night sweats, low energy, difficulty sleeping, difficulty concentrating, irritability, mild anxiety, muscle and joints aches and headaches. Helps to relieve symptoms associated with menopause (such as hot flashes, night sweats, low energy, difficulty sleeping, difficulty concentrating, irritability, mild anxiety, muscle and joint aches and headaches.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80108254
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.